Product Details
BIOTRONIK Conduction System Pacing Solution
Partnering closely with our physicians to advance CSP approaches and improve patient care.
Working alongside physicians and listening closely to their needs, we have together developed a complete Conduction System Pacing (CSP) Solution, consisting of the world's first and only approved MR Conditional CSP system1, comprehensive training, and expert technical support.
BIOTRONIK’s CSP system is composed of three proven components: Selectra 3D – a broad range of optimally designed catheters delivering excellent handling2; Solia S – the most popular choice of stylet-driven leads for LBBAP3, providing enhanced stability2; and Amvia – the first family of pacemakers approved for LBBAP.1
With a collaboratively developed system and practical training programs, BIOTRONIK’s CSP Solution gives you the confidence to undertake this innovative pacing approach. And we will continue to partner with you to further advance our CSP offering for the benefit of both you and your patients.
BIOTRONIK’s CSP Solution makes it easier for physicians to employ left bundle branch area pacing (LBBAP).4
BIOTRONIK's CSP Solution allows all physicians – including those new to left bundle area pacing (LBBAP) approach – to employ the technique with increased confidence and assurance.
Along with our knowledgeable technical team, we are dedicated to fostering confidence with comprehensive education and support for experienced physicians as well as those new to CSP.
Partnering closely with our physicians to advance CSP approaches and improve patient care.
1. BIOTRONIK Amvia technical manual; Medtronic Azure XT DR MRI SureScan™ manual; Boston Scientific Accolade MRI™ technical manual; Abbott Assurity MRI™ user’s manual; MicroPort Alizea™ implant manual. 2. De Pooter J, Bulava A, Gras D, et al. Utility of a guiding catheter for conduction system pacing. An early multicenter experience. Heart Rhythm O2. 2023; 288(24): 3115. 3. Jastrzębski M, Kiełbasa G, Cano O, et al. Left bundle branch area pacing outcomes: the multicentre European MELOS study. Eur Heart J. 2022; 43(40): 4161-4173. 4. Byeon K, Kim HR, Park SJ, Park YJ, Choi JH, Kim JY, Park KM, On YK, Kim JS. Initial Experience with Left Bundle Branch Area Pacing with Conventional Stylet-Driven Extendable Screw-In Leads and New Pre-Shaped Delivery Sheaths. J Clin Med. 2022 Apr 28;11(9):2483. 5. Burri H, Jastrzebski M, Cano Ó, et al. EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace. 2023; 25(4): 1208-1236.6. BIOTRONIK Selectra Catheter Technical Manual. 7. Data on file. 8. Sritharan A, Kozhuharov N, Masson N, Bakelants E, Valiton V, Burri H. Procedural outcome and follow-up of stylet-driven leads compared with lumenless leads for left bundle branch area pacing. Europace. 2023; 25(10): euad295. 9. Gillis K, O'Neill L, Wielandts JY, Hilfiker G, Vlase A, Knecht S, Duytschaever M, Tavernier R, le Polain de Waroux JB. Left bundle branch area pacing guided by continuous uninterrupted monitoring of unipolar pacing characteristics. J Cardiovasc Electrophysiol. 2022 Feb;33(2):299-307. doi: 10.1111/jce.15302). 10. Marcantoni L, Centioni M, Pastore G, et al. Conduction system pacing with Selectra 3D Sheath: Technical Results. Europace. 2022; 24(Supplement_1): i649. 11. Limited Warranty for BIOTRONIK Cardiac Implantable Electronic Devices; Medtronic Limited Warranty Summary; Boston Scientific Limited Warranty Information and Forms; Abbott CRM Warranty Procedures Reference Manual; MicroPort Alizea DR™/Alizea SR ™ Implant Manual.12. Yu GI, Kim TH, Yu HT, Joung B, Pak HN, Lee MH. Learning Curve Analyses for Left Bundle Branch Area Pacing with Conventional Stylet-Driven Pacing Leads. J Interv Cardiol. 2023; 2023: 3632257.
Disclaimer: BIOTRONIK CSP tools are not currently approved for conduction system pacing in the United States. Content not intended for US healthcare providers. Local regulatory approval may vary by country.